In summary, by inhibiting several aspects of the Fas/FasL signaling pathway, NF-κB signaling pathway, and JAK/STAT pathway, all of them can reduce the infection of COVID-19 to some extent and further prevent the development of ARDS. This evidence concerns the gene NFKB1 and acute respiratory distress syndrome.